GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » EPS (Basic)

Tauns Laboratories (TSE:197A) EPS (Basic) : 円-1.32 (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories EPS (Basic)?

Tauns Laboratories's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was 円0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was 円-1.32.

Tauns Laboratories's EPS (Diluted) for the three months ended in Dec. 2024 was 円0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was 円-1.32.

Tauns Laboratories's EPS without NRI for the three months ended in Dec. 2024 was 円0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -1.30.

During the past 12 months, Tauns Laboratories's average EPS without NRIGrowth Rate was 67.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Tauns Laboratories EPS (Basic) Historical Data

The historical data trend for Tauns Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories EPS (Basic) Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
EPS (Basic)
44.81 30.35 57.74

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24
EPS (Basic) - - - -1.32 -

Tauns Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Tauns Laboratories's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(5774.086-0)/100.000
=57.74

Tauns Laboratories's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0-0)/101.022
=0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tauns Laboratories  (TSE:197A) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Tauns Laboratories EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines